Literature DB >> 27202773

Medical Costs of Cardiovascular Diseases in Taiwan.

C H Tang1, P Y Chuang1, C A Chen1, Y C Fang2.   

Abstract

Entities:  

Year:  2014        PMID： 27202773     DOI： 10.1016/j.jval.2014.08.251

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  4 in total

1.  Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries.

Authors:  Bin Wu; Ruoyan Gai Tobe; Yuchen Liu; Ben He
Journal:  Clin Drug Investig       Date:  2018-07       Impact factor: 2.859

2.  Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study.

Authors:  Ying-Cheng Chen; Yin-Yang Chen; Han Wei Yeh; Tung-Ying Yeh; Jing-Yang Huang; Pei-Lun Liao; Liang-Tsai Yeh; Shun-Fa Yang; Ming-Chih Chou; Chao-Bin Yeh
Journal:  Front Public Health       Date:  2021-03-18

3.  Different Patterns in Ranking of Risk Factors for the Onset Age of Acute Myocardial Infarction between Urban and Rural Areas in Eastern Taiwan.

Authors:  Hsiu-Ju Huang; Chih-Wei Lee; Tse-Hsi Li; Tsung-Cheng Hsieh
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

4.  Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan.

Authors:  Lung Chan; Chen-Huan Chen; Juey-Jen Hwang; San-Jou Yeh; Kou-Gi Shyu; Ruey-Tay Lin; Yi-Heng Li; Larry Z Liu; Jim Z Li; Wen-Yi Shau; Te-Chang Weng
Journal:  Int J Gen Med       Date:  2016-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.